
VolitionRx Partners with Hologic to Expand Access to Epigenetic Testing Services
VolitionRx has entered a co-marketing agreement with Hologic to promote its Nu.Q® Discover epigenetic profiling service, expanding market access to pharmaceutical and biotech clients in the $200 million pharmaco-epigenetics sector.
Read full story



























